These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2459625)
1. [Development toward segmental and focal hyalinosis of a nephrotic syndrome with minimal glomerular lesions in a patient treated with sulindac]. Pagniez D; Gosset D; Hardouin P; Noël C; Delvallez L; Dequiedt P Nephrologie; 1988; 9(2):90-1. PubMed ID: 2459625 [No Abstract] [Full Text] [Related]
2. Nephrotic syndrome due to isolated minimal change glomerular disease in a patient taking pirprofen. Hannedouche T; Fournier JF; Moore N; Godin M; Fillastre JP Clin Nephrol; 1986 Jun; 25(6):314. PubMed ID: 3488152 [No Abstract] [Full Text] [Related]
3. Minimal change nephrotic syndrome associated with non steroidal antiinflammatory drugs. A need for careful evaluation. Labeeuw M; Cabanne JF; Dubot P Clin Nephrol; 1987 Mar; 27(3):162. PubMed ID: 3568464 [No Abstract] [Full Text] [Related]
4. Renal failure and nephrotic syndrome associated with sulindac. Champion de Crespigny PJ; Becker GJ; Ihle BU; Walter NM; Wright CA; Kincaid-Smith P Clin Nephrol; 1988 Jul; 30(1):52-5. PubMed ID: 3208459 [TBL] [Abstract][Full Text] [Related]
5. Glomerular tip lesion associated with nonsteroidal anti-inflammatory drug-induced nephrotic syndrome. Sekhon I; Munjal S; Croker B; Johnson RJ; Ejaz AA Am J Kidney Dis; 2005 Oct; 46(4):e55-8. PubMed ID: 16183408 [TBL] [Abstract][Full Text] [Related]
7. [Tiopronin-induced nephrotic syndrome with minimal glomerular lesions]. Lecoules S; Duvic C; Hérody M; Nédélec G Presse Med; 1999 Feb; 28(6):273-5. PubMed ID: 10073167 [TBL] [Abstract][Full Text] [Related]
8. [Minimal change glomerulonephritis, diffuse mesangioproliferative glomerulonephritis and focal and segmental glomerular sclerosis and hyalinosis]. Belovezhdov N Vutr Boles; 1984; 23(4):42-6. PubMed ID: 6506660 [TBL] [Abstract][Full Text] [Related]
9. Controlled clinical trial of imidazole.2-hydroxybenzoate (ITF 182) versus sulindac in patients with rheumatoid arthritis. Fumagalli M; Cunietti E; Vaiani G; Monti M; Ferrari F; Gandini R Clin Ther; 1986; 8(3):292-300. PubMed ID: 3521858 [TBL] [Abstract][Full Text] [Related]
10. [Results of a clinical study of a new anti-inflammatory analgesic: Sulindac]. Niccoli C Clin Ter; 1978 Jul; 86(1):61-9. PubMed ID: 311267 [No Abstract] [Full Text] [Related]
11. [Coumarin therapy during antirheumatism therapy with sulindac]. Schenk H; Klein G; Haralambus I; Goebel R Z Rheumatol; 1980; 39(3-4):102-8. PubMed ID: 6968485 [TBL] [Abstract][Full Text] [Related]
12. Immune hemolytic anemia associated with sulindac. Johnson FP; Hamilton HE; Liesch MR Arch Intern Med; 1985 Aug; 145(8):1515-6. PubMed ID: 4026480 [TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome due to sulindac: a case report and review of the literature. Maguire FW Del Med J; 1981 Apr; 53(4):193-7. PubMed ID: 7227578 [No Abstract] [Full Text] [Related]
17. The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Zech P; Colon S; Pointet P; Deteix P; Labeeuw M; Leitienne P Clin Nephrol; 1982 May; 17(5):232-6. PubMed ID: 7094440 [TBL] [Abstract][Full Text] [Related]